Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

The billionaire entrepreneur and CEO of IT services company World Wide Technology remains bullish about the future of AI.

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...

Plus, we'll look at the how gas prices can affect elections and do the numbers on the new COVID vaccine in this week's ...

Two years ago, the Leafs and the Dairy Farmers of Ontario (DFO) penned a multi-year deal to have the DFO's cursive "Milk" ...

Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at ...

Wall Street remains steady as economic reports align with expectations, with the S&P 500 inching up 0.1% in afternoon trading ...

International Emmys nominations are out, and three countries will battle for both the marquee Drama Series and Comedy Series prizes. Here the full list.

Shares of Moderna Inc. MRNA slipped 2.63% to $68.02 Thursday, on what proved to be an all-around favorable trading session ...